Medlab

Welcome to Medlab Clinical, we an ASX listed (MDC) Australian certified research company.
You may already be familiar with Medlab; after the sale of the Hall family’s BioCeuticals to Blackmores in 2012 – Medlab was born from the need to provide effective medical interventions and improving the lives of those with chronic disease.

We promote credible and clinically relevant science with our appointed team of experts with extensive experience in research, clinical practice, product development and delivery platforms; providing you access to the latest research, innovations and unique, targeted formulations that align disease to evidence-based treatments.

We focus on delivering new medicines for:

Obesity management, specifically in the pre-diabetic and type II diabetic areas, and non alcoholic fatty liver disease (NAFLD).

Chronic Kidney Disease (CKD), specifically in the early to moderate stages.

Depression, specifically in the early to moderate stages and medication resistant patients.

Anti-ageing, specifically musculoskeletal loss associated with the ageing process.

Pain management, specifically the role medical cannabis can play as an alternative to traditional opioid medication.

Delivery systems, utilising small particles for improved bioavailability and overall patient compliance.

Evidence - based nutraceuticals that can be used as an adjunct to the primary care of patients diagnosed with chronic diseases.

Our product range currently includes a range of unique combinations of Probiotics, Fish Oils (EPA:DHA), Magnesium; and Vitamin D3 and B12 sprays using patent pending nanotechnology.

Based in Alexandria, NSW Australia, Medlab operates its own purpose built biologics/biochemistry laboratory.

Medlab Clinical Ltd. is a proud member of Medicines Australia, AusBiotech and IPA.